| Patient | Joe Frazier |
|---|---|
| Date of birth | 1962-01-12 |
| Identifiers | MRN HR-BX004-SYN; SSN (made up) 000-04-5590 |
| Document date | 2026-02-16 |
| Author | Clarence Whitfield, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
High FIB-4 (3.43) with a mildly raised AST and low platelets at the yearly liver check in a 64-year-old man with type 2 diabetes, hypertension, low HDL, high triglycerides and obesity, who drinks little. Please stage his liver disease with elastography and advise on surveillance and treatment. [S]
Urgency: Within two weeks, with elastography and an ultrasound the same day. [S]
Questions for the consultant:
Former professional heavyweight boxer who runs a gym. Type 2 diabetes for about twelve years on metformin (A1c 8.4%); hypertension on lisinopril, above goal; LDL 132 mg/dL, HDL 38, triglycerides 210; BMI 31.4. Alcohol: one or two beers on some weekends (AUDIT-C 2); never smoked; no drug use. No history of jaundice, swelling or bleeding. Today: AST 48 and ALT 42 U/L, alkaline phosphatase 96, albumin 4.0 g/dL, bilirubin 0.9 mg/dL, platelets 138, hemoglobin 14.2, creatinine 1.08 mg/dL (eGFR 77), urine albumin-to-creatinine ratio 18 mg/g. FIB-4 3.43. Atorvastatin 40 mg started today. Hepatitis B, hepatitis C and HIV tests, iron studies and autoimmune tests sent. Reduced vision in the left eye since a cataract found at 20 [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1000 mg oral tablet, one tablet twice daily with meals; taken for years | One tablet twice daily with meals | Oral route | 2026-02-16 | active | S |
| Lisinopril 20 mg oral tablet, one tablet daily; taken for years | One tablet daily | Oral route | 2026-02-16 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-02-16 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes with hyperglycemia, about twelve years' duration, A1c 8.4% on metformin; synthetic modern episode linked to his publicly reported diabetes | active | confirmed | E11.65 | S — Synthetic modern diagnosis; diabetes was reported publicly during his life, but its duration and treatment here are synthetic. |
| Hypertension above goal on lisinopril (152/92 mmHg in the clinic); synthetic modern episode linked to his publicly reported high blood pressure | active | confirmed | I10 | S — Synthetic modern diagnosis; high blood pressure was reported publicly during his life. |
| Raised AST (48 U/L) with mildly low platelets (138) and a FIB-4 score of 3.43 at the yearly liver check, to be evaluated | active | confirmed | R74.01 | S — Synthetic presenting finding, superseded at the two-week visit by the elastography and ultrasound diagnosis. |
| Hyperlipidemia: LDL 132 mg/dL, HDL 38 and triglycerides 210, not on a statin | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Obesity, class 1 (BMI 31.4) | active | confirmed | E66.811 | S — Synthetic finding; described without stigma. |
| Reduced vision in the left eye since a cataract found at 20 (counting fingers at 1 meter); right eye 20/30 | active | confirmed | H54.62 | S — Synthetic modern measurement anchored to the documented cataract in his left eye. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1964 | Broken left thumb in the 1964 Olympic final | D (CLM-0003) |
| 1964 | Cataract in the left eye found at 20, with reduced vision in that eye through his boxing career (20/400 in that eye by 1975) | D (CLM-0004) |
| 1965 to 1976, and one bout in 1981 | Professional heavyweight boxing career with many blows to the head, including a 1975 bout stopped when he could no longer see | D (CLM-0005, CLM-0006) |
| early 2000s | Diabetes and high blood pressure, reported publicly | D (CLM-0008) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-16 | Body height | 182 | cm | S |
| 2026-02-16 | Body weight | 104 | kg | S |
| 2026-02-16 | Body mass index (BMI) [Ratio] | 31.4 | kg/m2 | S |
| 2026-02-16 | Systolic blood pressure | 152 | mm[Hg] | S |
| 2026-02-16 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 2026-02-16 | Heart rate | 76 | /min | S |
| 2026-02-16 | Respiratory rate | 16 | /min | S |
| 2026-02-16 | Body temperature | 36.7 | Cel | S |
| 2026-02-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 8.4 | % | Below 5.7% is normal; goal below 7% for him | High | S |
| 2026-02-16 | Glucose [Mass/volume] in Serum or Plasma | 168 | mg/dL | 70-99 mg/dL | High | S |
| 2026-02-16 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-02-16 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-02-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-02-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 77 | mL/min/{1.73_m2} | 60 or higher without kidney damage markers is not CKD | Normal | S |
| 2026-02-16 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g | Below 30 mg/g is normal (A1) | Normal | S |
| 2026-02-16 | Cholesterol [Mass/volume] in Serum or Plasma | 212 | mg/dL | <=199 mg/dL | High | S |
| 2026-02-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | Goal below 70 mg/dL with diabetes and other risk factors | High | S |
| 2026-02-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 2026-02-16 | Triglyceride [Mass/volume] in Serum or Plasma | 210 | mg/dL | <=149 mg/dL | High | S |
| 2026-02-16 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 48 | U/L | 10-40 U/L | High | S |
| 2026-02-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 42 | U/L | 7-55 U/L | Normal | S |
| 2026-02-16 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 96 | U/L | 40-129 U/L | Normal | S |
| 2026-02-16 | Albumin [Mass/volume] in Serum or Plasma | 4 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-02-16 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.9 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-02-16 | Hemoglobin [Mass/volume] in Blood | 14.2 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-02-16 | Platelets [#/volume] in Blood by Automated count | 138 | 10*3/uL | 150-400 10*3/uL | Low | S |
| 2026-02-16 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 340 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-02-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-02-16 | Total score [AUDIT-C] | 2 | {score} | S |